Skip to search formSkip to main contentSkip to account menu

mcrC protein, E coli

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DNA Restriction EnzymesEscherichia coli Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A phase II clinical study of combining FOLFIRI and bevacizumab plus erlotinib in 2nd-line chemotherapy for patients with metastatic colorectal cancer
Abstract We conducted an open-label single-arm phase II study by combining irinotecan (FOLFIRI) and bevacizumab (BV) plus… 
2017
2017
ANALÝZA NÁKLADŮ NA LÉČBU CETUXIMABEM A PANITUMUMABEM V 1. LINII LÉČBY MCRC
Review
2014
Review
2014
Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.
2011
2011
A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining
SummaryPurpose To determine antitumor activity of cetuximab monotherapy in patients with refractory metastatic colorectal… 
2008
2008
Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era
The epidermal growth factor receptor (EGFR) is commonly expressed in colorectal cancer and is widely recognized as an important… 
Review
2008
Review
2008
Controversial evaluation of EGFR protein and gene status in predicting response to anti-EGFR monoclonal antibodies in metastatic colorectal cancer: a case report and review of the literature
Clinical studies showed that only 10% of patients with metastatic colorectal cancer (mCRC) respond to treatment with the anti… 
2006
2006
Mucinous Colorectal Cancers With Chromosomal Instability: A Biologically Distinct and Aggressive Subtype
Colorectal cancers can progress through 2 pathways of genomic instability: microsatellite instability (MSI) and chromosomal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)